Melanotan 1 (Afamelanotide)

Melanotan 1, also known as Afamelanotide, is a synthetic analog of alpha-melanocyte stimulating hormone (α-MSH) that selectively activates MC1R. Commonly administered via subcutaneous injection or nasal spray for tanning. FDA-approved as Scenesse (16 mg subcutaneous implant) for erythropoietic protoporphyria (EPP).

At a Glance

Summary: Selectively activates MC1R receptors on melanocytes, stimulating eumelanin production for photoprotection without significant sexual side effects. Mechanisms (reported/proposed across domains): Skin / cosmetic • Selectively binds MC1R on melanocytes, stimulating eumelanin (brown/black pigment) synthesis. • Provides photoprotection by increasing melanin density before UV exposure,...

Safety Profile

FDA Approved for EPP

Research Dosing

Dose: 0.08–0.16 mg/kg (SC injection) · Route: Subcutaneous (SC) · Nasal Spray · Frequency: Daily for 10 days (clinical trials) · Duration: 10–28 days (study protocols)

Categories

  • FDA Approved
  • Tanning
  • Melanin Production
  • Photoprotection
  • MC1R Selective
  • EPP Treatment
  • Clinical Data Available
  • Skin Health

Related Peptides

The Leading Community for Trusted Peptide Research & Insights

Join a vibrant community sharing real peptide experiences, clinical research, and proven protocols. Data-backed, open, and censorship-free.